Epigenetic impacts on neurodevelopment: Pathophysiological mechanisms and genetic modes of action

Pediatric Research

Volumn 69, Issue 5 PART 2, 2011, Pages

  Zahir, Farah R ^a   Brown, Carolyn J ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTISM; EPIGENETICS; GENOME; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; INTELLECTUAL IMPAIRMENT; MENTAL DEFICIENCY; NERVE CELL DIFFERENTIATION; PATHOGENESIS; PATHOGENICITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SCHIZOPHRENIA;

CENTRAL NERVOUS SYSTEM; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; EPIGENESIS, GENETIC; HUMANS; MENTAL RETARDATION; PHENOTYPE; SCHIZOPHRENIA;

EID: 79954590474     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/PDR.0b013e318213565e     Document Type: Article

References (100)

1. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, et al. 2001 Initial sequencing and analysis of the human genome. Nature 409:860-921 (Pubitemid 32165345)
2. Kramer JM, van Bokhoven H 2009 Genetic and epigenetic defects in mental retardation. Int J Biochem Cell Biol 41:96-107
3. Ropers HH 2010 Genetics of early onset cognitive impairment. Annu Rev Genom-ics Hum Genet 11:161-187
4. Urdinguio RG, Sanchez-Mut JV, Esteller M 2009 Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies. Lancet Neurol 8:1056-1072
5. Gräff J, Mansuy IM 2009 Epigenetic dysregulation in cognitive disorders. Eur J Neurosci 30:1-8
6. Illingworth RS, Bird AP 2009 CpG islands\'arough guide'. FEBS Lett 583:1713-1720
7. Bird A 2002 DNA methylation patterns and epigenetic memory. Genes Dev 16:6-21 (Pubitemid 34049633)
8. Laird PW 2010 Principles and challenges of genome-wide DNA methylation analysis. Nat Rev Genet 11:191-203
9. Suzuki MM, Bird A 2008 DNA methylation landscapes: provocative insights from epigenomics. Nat Rev Genet 9:465-476 (Pubitemid 351693975)
10. Kouzarides T 2007 Chromatin modifications and their function. Cell 128:693-705 (Pubitemid 46273577)
11. Yoo AS, Crabtree GR 2009 ATP-dependent chromatin remodeling in neural development. Curr Opin Neurobiol 19:120-126
12. Vaissière T, Sawan C, Herceg Z 2008 Epigenetic interplay between histone modifications and DNA methylation in gene silencing. Mutat Res 659:40-48
13. Riccio A 2010 Dynamic epigenetic regulation in neurons: enzymes, stimuli and signaling pathways. Nat Neurosci 13:1330-1337
14. Gavin DP, Sharma RP 2010 Histone modifications, DNA methylation, and schizo-phrenia. Neurosci Biobehav Rev 34:882-888
15. MacDonald JL, Roskams AJ 2009 Epigenetic regulation of nervous system devel-opment by DNA methylation and histone deacetylation. Prog Neurobiol 88:170-183
16. Leonard H, Wen X 2002 The epidemiology of mental retardation: challenges and opportunities in the new millennium. Ment Retard Dev Disabil Res Rev 8:117-134 (Pubitemid 36378154)
17. Inlow JK, Restifo LL 2004 Molecular and comparative genetics of mental retar-dation. Genetics 166:835-881 (Pubitemid 38391747)
18. Chelly J, Khelfaoui M, Francis F, Cherif B, Bienvenu T 2006 Genetics and pathophysiology of mental retardation. Eur J Hum Genet 14:701-713 (Pubitemid 43797267)
19. Pickering DL, Eudy JD, Olney AH, Dave BJ, Golden D, Stevens J, Sanger WG 2008 Array-based comparative genomic hybridization analysis of 1176 consecutive clinical genetics investigations. Genet Med 10:262-266 (Pubitemid 351544128)
20. Manolakos E, Vetro A, Kefalas K, Rapti SM, Louizou E, Garas A, Kitsos G, Vasileiadis L, Tsoplou P, Eleftheriades M, Peitsidis P, Orru S, Liehr T, Petersen MB, Thomaidis L 2010 The use of array-CGH in a cohort of Greek children with developmental delay. Mol Cytogenet 3:22
21. Friedman J, Adam S, Arbour L, Armstrong L, Baross A, Birch P, Boerkoel C, Chan S, Chai D, Delaney AD, Flibotte S, Gibson WT, Langlois S, Lemyre E, Li HI, MacLeod P, Mathers J, Michaud JL, McGillivray BC, Patel MS, Qian H, Rouleau GA, Van Allen MI, Yong SL, Zahir FR, Eydoux P, Marra MA 2009 Detection of pathogenic copy number variants in children with idiopathic intellectual disability using 500 K SNP array genomic hybridization. BMC Genomics 10:526
22. Esteller M 2007 Rett syndrome: the first forty years: 1966-2006. Epigenetics 2:1 (Pubitemid 46824842)
23. Amir RE, Van den Veyver IB, Schultz R, Malicki DM, Tran CQ, Dahle EJ, Philippi A, Timar L, Percy AK, Motil KJ, Lichtarge O, Smith EO, Glaze DG, Zoghbi HY 2000 Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes. Ann Neurol 47:670-679 (Pubitemid 30261908)
24. Gonzales ML, LaSalle JM 2010 The role of MeCP2 in brain development and neurodevelopmental disorders. Curr Psychiatry Rep 12:127-134
25. Taine L, Goizet C, Wen ZQ, Petrij F, Breuning MH, Ayme S, Saura R, Arveiler B, Lacombe D 1998 Submicroscopic deletion of chromosome 16p13.3 inpatients with Rubinstein-Taybi syndrome. Am J Med Genet 78:267-270 (Pubitemid 28307543)
26. Kalkhoven E, Roelfsema JH, Teunissen H, den Boer A, Ariyurek Y, Zantema A, Breuning MH, Hennekam RC, Peters DJ 2003 Loss of CBP acetyltransferase activity by PHD finger mutations in Rubinstein-Taybi syndrome. Hum Mol Genet 12:441-450 (Pubitemid 36285136)
27. Trivier E, De Cesare D, Jacquot S, Pannetier S, Zackai E, Young I, Mandel JL, Sassone-Corsi P, Hanauer A 1996 Mutations in the kinase Rsk-2 associated with Coffin-Lowry syndrome. Nature 384:567-570 (Pubitemid 26415934)
28. Nakajima T, Fukamizu A, Takahashi J, Gage FH, Fisher T, Blenis J, Montminy MR 1996 The signal-dependent coactivator CBP is a nuclear target for pp90RSK. Cell 86:465-474 (Pubitemid 26272086)
29. Ehrlich M 2003 The ICF syndrome, a DNA methyltransferase 3B deficiency and immunodeficiency disease. Clin Immunol 109:17-28 (Pubitemid 37324738)
30. Xue Y, Gibbons R, Yan Z, Yang D, McDowell TL, Sechi S, Qin J, Zhou S, Higgs D, Wang W 2003 The ATRX syndrome protein forms a chromatin-remodeling complex with Daxx and localizes in promyelocytic leukemia nuclear bodies. Proc Natl Acad Sci USA 100:10635-10640 (Pubitemid 37140081)
31. Vissers LE, van Ravenswaaij CM, Admiraal R, Hurst JA, de Vries BB, Janssen IM, van der Vliet WA, Huys EH, de Jong PJ, Hamel BC, Schoenmakers EF, Brunner HG, Veltman JA, van Kessel AG 2004 Mutations in a new member of the chromodomain gene family cause CHARGE syndrome. Nat Genet 36:955-957 (Pubitemid 39167490)
32. Biliya S, Bulla LA Jr 2010 Genomic imprinting: the influence of differential methylation in the two sexes. Exp Biol Med (Maywood) 235:139-147
33. Knoll JH, Nicholls RD, Magenis RE, Graham JM Jr, Lalande M, Latt SA 1989 Angelman and Prader-Willi syndromes share a common chromosome 15 deletion but differ in parental origin of the deletion. Am J Med Genet 32:285-290
34. Buiting K 2010 Prader-Willi syndrome and Angelman syndrome. Am J Med Genet C Semin Med Genet 154C:365-376
35. Bolton PF, Dennis NR, Browne CE, Thomas NS, Veltman MW, Thompson RJ, Jacobs P 2001 The phenotypic manifestations of interstitial duplications of proxi-mal 15q with special reference to the autistic spectrum disorders. Am J Med Genet 105:675-685 (Pubitemid 33101466)
36. Dimitropoulos A, Schultz RT 2007 Autistic-like symptomatology in Prader-Willi syndrome: a review of recent findings. Curr Psychiatry Rep 9:159-164 (Pubitemid 46579154)
37. Piard J, Philippe C, Marvier M, Beneteau C, Roth V, Valduga M, Beri M, Bonnet C, Gregoire MJ, Jonveaux P, Leheup B 2010 Clinical and molecular characteriza-tion of a large family with an interstitial 15q11q13 duplication. Am J Med Genet A 152A:1933-1941
38. Shinawi M, Liu P, Kang SH, Shen J, Belmont JW, Scott DA, Probst FJ, Craigen WJ, Graham BH, Pursley A, Clark G, Lee J, Proud M, Stocco A, Rodriguez DL, Kozel BA, Sparagana S, Roeder ER, McGrew SG, Kurczynski TW, Allison LJ, Amato S, Savage S, Patel A, Stankiewicz P, Beaudet AL, Cheung SW, Lupski JR 2010 Recurrent reciprocal 16p11.2 rearrangements associated with global devel-opmental delay, behavioural problems, dysmorphism, epilepsy, and abnormal head size. J Med Genet 47:332-341
39. Phelan MC 2008 Deletion 22q13.3 syndrome. Orphanet J Rare Dis 3:14
40. Psoni S, Sofocleous C, Traeger-Synodinos J, Kitsiou-Tzeli S, Kanavakis E, Frys-sira-Kanioura H 2010 Phenotypic and genotypic variability in four males with MECP2 gene sequence aberrations including a novel deletion. Pediatr Res 67:551-556
41. Perrin M, Kleinhaus K, Messinger J, Malaspina D 2010 Critical periods and the developmental origins of disease: an epigenetic perspective of schizophrenia. Ann N Y Acad Sci 1204:E8-E13
42. Brown AS 2011 The environment and susceptibility to schizophrenia. Prog Neurobiol 93:23-58
43. Kim T, Park JK, Kim HJ, Chung JH, Kim JW 2010 Association of histone deacetylase genes with schizophrenia in Korean population. Psychiatry Res 178:266-269
44. Sharma RP, Grayson DR, Gavin DP 2008 Histone deactylase 1 expression is increased in the prefrontal cortex of schizophrenia subjects: analysis of the National Brain Databank microarray collection. Schizophr Res 98:111-117 (Pubitemid 350235899)
45. Benes FM, Lim B, Matzilevich D, Subburaju S, Walsh JP 2008 Circuitry-based gene expression profiles in GABA cells of the trisynaptic pathway in schizophren-ics versus bipolars. Proc Natl Acad Sci USA 105:20935-20940
46. Knight CG, Zitzmann N, Prabhakar S, Antrobus R, Dwek R, Hebestreit H, Rainey PB 2006 Unraveling adaptive evolution: how a single point mutation affects the protein coregulation network. Nat Genet 38:1015-1022 (Pubitemid 44325926)
47. Moretti P, Zoghbi HY 2006 MeCP2 dysfunction in Rett syndrome and related disorders. Curr Opin Genet Dev 16:276-281 (Pubitemid 43732423)
48. Chahrour M, Zoghbi HY 2007 The story of Rett syndrome: from clinic to neurobiology. Neuron 56:422-437 (Pubitemid 350026269)
49. Martin CL, Duvall JA, Ilkin Y, Simon JS, Arreaza MG, Wilkes K, Alvarez-Retuerto A, Whichello A, Powell CM, Rao K, Cook E, Geschwind DH 2007 Cytogenetic and molecular characterization of A2BP1/FOX1 as a candidate gene for autism. Am J Med Genet B Neuropsychiatr Genet 144B:869-876 (Pubitemid 47547986)
50. Bhalla K, Phillips HA, Crawford J, McKenzie OL, Mulley JC, Eyre H, Gardner AE, Kremmidiotis G, Callen DF 2004 The de novo chromosome 16 translocations of two patients with abnormal phenotypes (mental retardation and epilepsy) disrupt the A2BP1 gene. J Hum Genet 49:308-311 (Pubitemid 38899706)
51. Verbruggen KT, Knijff WA, Soorani-Lunsing RJ, Sijens PE, Verhoeven NM, Salomons GS, Goorhuis-Brouwer SM, van Spronsen FJ 2007 Global developmen-tal delay in guanidionacetate methyltransferase deficiency: differences in formal testing and clinical observation. Eur J Pediatr 166:921-925 (Pubitemid 47101345)
52. Begni S, Moraschi S, Bignotti S, Fumagalli F, Rillosi L, Perez J, Gennarelli M 2003 Association between the G1001C polymorphism in the GRIN1 gene promoter region and schizophrenia. Biol Psychiatry 53:617-619 (Pubitemid 36385063)
53. Rice SR, Niu N, Berman DB, Heston LL, Sobell JL 2001 Identification of single nucleotide polymorphisms (SNPs) and other sequence changes and estimation of nucleotide diversity in coding and flanking regions of the NMDAR1 receptor gene in schizophrenic patients. Mol Psychiatry 6:274-284 (Pubitemid 32275672)
54. Zhao X, Li H, Shi Y, Tang R, Chen W, Liu J, Feng G, Shi J, Yan L, Liu H, He L 2006 Significant association between the genetic variations in the 5' end of the N-methyl-D-aspartate receptor subunit gene GRIN1 and schizophrenia. Biol Psychiatry 59:747-753
55. Rottach A, Leonhardt H, Spada F 2009 DNA methylation-mediated epigenetic control. J Cell Biochem 108:43-51
56. Portela A, Esteller M 2010 Epigenetic modifications and human disease. Nat Biotechnol 28:1057-1068
57. Easwaran HP, Schermelleh L, Leonhardt H, Cardoso MC 2004 Replication-independent chromatin loading of Dnmt1 during G2 and M phases. EMBO Rep 5:1181-1186 (Pubitemid 40103614)
58. Biniszkiewicz D, Gribnau J, Ramsahoye B, Gaudet F, Eggan K, Humpherys D, Mastrangelo MA, Jun Z, Walter J, Jaenisch R 2002 Dnmt1 overexpression causes genomic hypermethylation, loss of imprinting, and embryonic lethality. Mol Cell Biol 22:2124-2135 (Pubitemid 34224620)
59. Li E, Bestor TH, Jaenisch R 1992 Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69:915-926
60. Rhee I, Bachman KE, Park BH, Jair KW, Yen RW, Schuebel KE, Cui H, Feinberg AP, Lengauer C, Kinzler KW, Baylin SB, Vogelstein B 2002 DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature 416:552-556 (Pubitemid 34288859)
61. Girirajan S, Rosenfeld JA, Cooper GM, Antonacci F, Siswara P, Itsara A, Vives L, Walsh T, McCarthy SE, Baker C, Mefford HC, Kidd JM, Browning SR, Browning BL, Dickel DE, Levy DL, Ballif BC, Platky K, Farber DM, Gowans GC, Weth-erbee JJ, Asamoah A, Weaver DD, Mark PR, Dickerson J, Garg BP, Ellingwood SA, Smith R, Banks VC, Smith W, McDonald MT, Hoo JJ, French BN, Hudson C, Johnson JP, Ozmore JR, Moeschler JB, Surti U, Escobar LF, El-Khechen D, Gorski JL, Kussmann J, Salbert B, Lacassie Y, Biser A, McDonald-McGinn DM, Zackai EH, DeardorffMA, Shaikh TH, Haan E, Friend KL, Fichera M, Romano C, Gécz J, DeLisi LE, Sebat J, King MC, Shaffer LG, Eichler EE 2010 A recurrent 16p12.1 microdeletion supports a two-hit model for severe developmental delay. Nat Genet 42:203-209
62. Lee C, Scherer SW 2010 The clinical context of copy number variation in the human genome. Expert Rev Mol Med 12:e8
63. Coupry I, Monnet L, Attia AA, Taine L, Lacombe D, Arveiler B 2004 Analysis of CBP (CREBBP) gene deletions in Rubinstein-Taybi syndrome patients using real-time quantitative PCR. Hum Mutat 23:278-284 (Pubitemid 38337892)
64. Stef M, Simon D, Mardirossian B, Delrue MA, Burgelin I, Hubert C, Marche M, Bonnet F, Gorry P, Longy M, Lacombe D, Coupry I, Arveiler B 2007 Spectrum of CREBBP gene dosage anomalies in Rubinstein-Taybi syndrome patients. Eur J Hum Genet 15:843-847 (Pubitemid 47109043)
65. Thienpont B, Béna F, Breckpot J, Philip N, Menten B, Van Esch H, Scalais E, Salamone JM, Fong CT, Kussmann JL, Grange DK, Gorski JL, Zahir F, Yong SL, Morris MM, Gimelli S, Fryns JP, Mortier G, Friedman JM, Villard L, Bottani A, Vermeesch JR, Cheung SW, Devriendt K 2010 Duplications of the critical Rubin-stein-Taybi deletion region on chromosome 16p13.3 cause a novel recognisable syndrome. J Med Genet 47:155-161
66. Marangi G, Leuzzi V, Orteschi D, Grimaldi ME, Lecce R, Neri G, Zollino M 2008 Duplication of the Rubinstein-Taybi region on 16p13.3 is associated with a distinctive phenotype. Am J Med Genet A 146A:2313-2317
67. Bannister AJ, Kouzarides T 1996 The CBP co-activator is a histone acetyltrans-ferase. Nature 384:641-643
68. Burmeister M, McInnis MG, Zollner S 2008 Psychiatric genetics: progress amid controversy. Nat Rev Genet 9:527-540 (Pubitemid 351972757)
69. Inoue K, Lupski JR 2003 Genetics and genomics of behavioral and psychiatric disorders. Curr Opin Genet Dev 13:303-309 (Pubitemid 36645095)
70. Singh SM, Basu D 2009 The P300 event-related potential and its possible role as an endophenotype for studying substance use disorders: a review. Addict Biol 14:298-309
71. Sacco R, Militerni R, Frolli A, Bravaccio C, Gritti A, Elia M, Curatolo P, Manzi B, Trillo S, Lenti C, Saccani M, Schneider C, Melmed R, Reichelt KL, Pascucci T, Puglisi-Allegra S, Persico AM 2007 Clinical, morphological, and biochemical correlates of head circumference in autism. Biol Psychiatry 62:1038-1047 (Pubitemid 47562373)
72. Aylward EH, Minshew NJ, Field K, Sparks BF, Singh N 2002 Effects of age on brain volume and head circumference in autism. Neurology 59:175-183 (Pubitemid 34779173)
73. Fidler DJ, Bailey JN, Smalley SL 2000 Macrocephaly in autism and other pervasive developmental disorders. Dev Med Child Neurol 42:737-740
74. Hazlett HC, Poe M, Gerig G, Smith RG, Provenzale J, Ross A, Gilmore J, Piven J 2005 Magnetic resonance imaging and head circumference study of brain size in autism: birth through age 2 years. Arch Gen Psychiatry 62:1366-1376 (Pubitemid 41746614)
75. Gur RE, Gur RC 2010 Functional magnetic resonance imaging in schizophrenia. Dialogues Clin Neurosci 12:333-343
76. Hamer D 2002 Genetics. Rethinking behavior genetics. Science 298:71-72
77. Fukuda T, Itoh M, Ichikawa T, Washiyama K, Goto Y 2005 Delayed maturation of neuronal architecture and synaptogenesis in cerebral cortex of Mecp2-deficient mice. J Neuropathol Exp Neurol 64:537-544 (Pubitemid 40781157)
78. Feng J, Chang H, Li E, Fan G 2005 Dynamic expression of de novo DNA methyltransferases Dnmt3a and Dnmt3b in the central nervous system. J Neurosci Res 79:734-746 (Pubitemid 40476498)
79. Ueda Y, Okano M, Williams C, Chen T, Georgopoulos K, Li E 2006 Roles for Dnmt3b in mammalian development: a mouse model for the ICF syndrome. Development 133:1183-1192
80. Matarazzo V, Cohen D, Palmer AM, Simpson PJ, Khokhar B, Pan SJ, Ronnett GV 2004 The transcriptional repressor Mecp2 regulates terminal neuronal differentiation. Mol Cell Neurosci 27:44-58 (Pubitemid 39179351)
81. Hendrich B, Guy J, Ramsahoye B, Wilson VA, Bird A 2001 Closely related proteins MBD2 and MBD3 play distinctive but interacting roles in mouse devel-opment. Genes Dev 15:710-723 (Pubitemid 32244900)
82. Endres M, Fan G, Meisel A, Dirnagl U, Jaenisch R 2001 Effects of cerebral ischemia in mice lacking DNA methyltransferase 1 in post-mitotic neurons. Neuroreport 12:3763-3766 (Pubitemid 33105167)
83. Kim HG, Kurth I, Lan F, Meliciani I, Wenzel W, Eom SH, Kang GB, Rosenberger G, Tekin M, Ozata M, Bick DP, Sherins RJ, Walker SL, Shi Y, Gusella JF, Layman LC 2008 Mutations in CHD7, encoding a chromatin-remodeling protein, cause idiopathic hypogonadotropic hypogonadism and Kallmann syndrome. Am J Hum Genet 83:511-519
84. Allan AM, Liang X, Luo Y, Pak C, Li X, Szulwach KE, Chen D, Jin P, Zhao X 2008 The loss of methyl-CpG binding protein 1 leads to autism-like behavioral deficits. Hum Mol Genet 17:2047-2057 (Pubitemid 351865853)
85. Muhle R, Trentacoste SV, Rapin I 2004 The genetics of autism. Pediatrics 113:e472-e486
86. Schneider A, Hagerman RJ, Hessl D 2009 Fragile X syndrome\from genes to cognition. Dev Disabil Res Rev 15:333-342
87. Zimmermann S, Kiefer F, Prudenziati M, Spiller C, Hansen J, Floss T, Wurst W, Minucci S, Gottlicher M 2007 Reduced body size and decreased intestinal tumor rates in HDAC2-mutant mice. Cancer Res 67:9047-9054 (Pubitemid 47535889)
88. Huang HS, Matevossian A, Whittle C, Kim SY, Schumacher A, Baker SP, Akbarian S 2007 Prefrontal dysfunction in schizophrenia involves mixed-lineage leukemia 1-regulated histone methylation at GABAergic gene promoters. J Neurosci 27:11254-11262 (Pubitemid 47621326)
89. Veldic M, Kadriu B, Maloku E, Agis-Balboa RC, Guidotti A, Davis JM, Costa E 2007 Epigenetic mechanisms expressed in basal ganglia GABAergic neurons differentiate schizophrenia from bipolar disorder. Schizophr Res 91:51-61
90. Costa E, Chen Y, Dong E, Grayson DR, Kundakovic M, Maloku E, Ruzicka W, Satta R, Veldic M, Zhubi A, Guidotti A 2009 GABAergic promoter hypermethyl-ation as a model to study the neurochemistry of schizophrenia vulnerability. Expert Rev Neurother 9:87-98
91. Van Winkel R, Esquivel G, Kenis G, Wichers M, Collip D, Peerbooms O, Rutten B, Myin-Germeys I, Van Os J 2010 REVIEW: Genome-wide findings in schizophrenia and the role of gene-environment interplay. CNS Neurosci Ther 16:e185-e192
92. Archer T, Kostrzewa RM, Beninger RJ, Palomo T 2010 Staging perspectives in neurodevelopmental aspects of neuropsychiatry: agents, phases and ages at expression. Neurotox Res 18:287-305
93. van Os J, Kenis G, Rutten BP 2010 The environment and schizophrenia. Nature 468:203-212
94. Waterland RA, Dolinoy DC, Lin JR, Smith CA, Shi X, Tahiliani KG 2006 Maternal methyl supplements increase offspring DNA methylation at Axin Fused. Genesis 44:401-406 (Pubitemid 44454044)
95. Numachi Y, Yoshida S, Yamashita M, Fujiyama K, Naka M, Matsuoka H, Sato M, Sora I 2004 Psychostimulant alters expression of DNA methyltransferase mRNA in the rat brain. Ann N Y Acad Sci 1025:102-109 (Pubitemid 39643851)
96. Tremolizzo L, Doueiri MS, Dong E, Grayson DR, Davis J, Pinna G, Tueting P, Rodriguez-Menendez V, Costa E, Guidotti A 2005 Valproate corrects the schizo-phrenia-like epigenetic behavioral modifications induced by methionine in mice. Biol Psychiatry 57:500-509 (Pubitemid 40311985)
97. Weaver IC, Meaney MJ, Szyf M 2006 Maternal care effects on the hippocampal transcriptome and anxiety-mediated behaviors in the offspring that are reversible in adulthood. Proc Natl Acad Sci USA 103:3480-3485 (Pubitemid 43346494)
98. Oh G, Petronis A 2008 Environmental studies of schizophrenia through the prism of epigenetics. Schizophr Bull 34:1122-1129
99. Firth HV, Richards SM, Bevan AP, Clayton S, Corpas M, Rajan D, Van Vooren S, Moreau Y, Pettett RM, Carter NP 2009 DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources. Am J Hum Genet 84:524-533
100. McEwen BS 2010 Stress, sex, and neural adaptation to a changing environment: mechanisms of neuronal remodeling. Ann N Y Acad Sci 1204:E38-E59